BioLineRx (BLRX) Return on Capital Employed Growth (5y) (2018 - 2025)
BioLineRx (BLRX) Return on Capital Employed Growth (5y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | BioLineRx | 7.05 Bn | 7.06 Bn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2,721.00 |
| Sep 30, 2025 | 2,715.00 |
| Jun 30, 2025 | 2,222.00 |
| Mar 31, 2025 | 994.00 |
| Dec 31, 2024 | -236.00 |
| Sep 30, 2024 | -5,051.00 |
| Jun 30, 2024 | -10,551.00 |
| Mar 31, 2024 | -12,737.00 |
| Dec 31, 2023 | -26,097.00 |
| Sep 30, 2023 | -3,685.00 |
| Jun 30, 2023 | -1,117.00 |
| Mar 31, 2023 | -205.00 |
| Dec 31, 2022 | 176.00 |
| Sep 30, 2022 | -392.00 |
| Jun 30, 2022 | -146.00 |
| Mar 31, 2022 | 1,492.00 |
| Dec 31, 2021 | 1,141.00 |
| Sep 30, 2021 | 944.00 |
| Jun 30, 2021 | 549.00 |
| Mar 31, 2021 | -610.00 |